New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2012
16:24 EDTHEB, RGR, NLSN, SWHC, GTAT, ARB, ORCLOn The Fly: Closing Wrap
Stocks on Wall Street were higher, with the buying spurred on by optimism surrounding the fiscal cliff negotiations. After surging higher during the first half of the trading session, the averages moved in a narrow range through the afternoon, though held onto gains and closed right near their highs... ECONOMIC EVENTS: In the U.S., the National Association of Home Builders index of builder confidence increased to 47, as was forecast. Also, the current-account deficit in the U.S. narrowed in the third quarter to $107.5B from a $118.1B shortfall in the prior quarter. Economists expected the deficit would narrow to about $103B... COMPANY NEWS: After the bell, Oracle (ORCL) reported earnings and revenues that beat Street expectations. Shares, which had been up 1.67% during the trading session, moved up another 1.5% in after hours trading following the report... Gunmakers Smith & Wesson (SWHC) and Sturm, Ruger (RGR) continued their recent weakness as private equity firm Cerberus Capital Management's decision to put gunmaker Freedom Group up for sale added new pressure on those stocks. Shares of Smith & Wesson lost 86c, or 9.99%, to close at $7.79, while shares of Sturm, Ruger fell $3.40, or 7.73%, to close at $40.60... MAJOR MOVERS: Among the notable gainers was Arbitron (ARB), up $8.99, or 23.63%, to $47.03 after agreeing to be bought by Nielsen (NLSN) for $48 per share in cash. Shares of acquirer Nielsen also gained $1.30, or 4.39%, to $30.92. Among the noteworthy losers was GT Advanced Technologies (GTAT), which was downgraded at Raymond James and Stifel Nicolaus and saw shares fall 39c, or 11.27%, to $3.07 after issuing guidance well below consensus. Also lower was Hemispherex Biopharma (HEB), down 27.6c, or 42.86%, to 36.8c, after the FDA posted documents in advance of a review of the company's Ampligen drug, noting that the agency had concerns with the drug's efficacy and safety data... INDICES: The Dow was up 115.57, or 0.87%, to 13,350.96; the Nasdaq was up 43.93, or 1.46%, to 3,054.53; and the S&P 500 was up 16.43, or 1.15%, to 1,446.79.
News For ORCL;SWHC;RGR;ARB;NLSN;HEB;GTAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 4, 2015
11:10 EDTORCLOracle volatility elevated into Q1 and outlook
Oracle September call option implied volatility is at 39, October is at 32; compared to its 52-week range of 15 to 39, suggesting large near term price movement into the expected release of Q1 results on September 16.
September 2, 2015
10:16 EDTSWHCOptions with decreasing implied volatility
Subscribe for More Information
September 1, 2015
08:01 EDTORCLOracle granted ATO by DoD
Oracle Service Cloud has received an Authority to Operate, or ATO, from the U.S Department of Defense, or DoD, under the DoD Cloud Security Model at security impact Level 4. The Oracle Service Cloud is Oracle's premier SaaS solution providing the industry's best-in-class customer service platform for enterprise customers.
August 28, 2015
12:50 EDTSWHCOn The Fly: Top stock stories at midday
Subscribe for More Information
11:38 EDTRGR, SWHCSmith & Wesson rallies after beating Q2 estimates, raising FY16 guidance
Subscribe for More Information
09:23 EDTSWHCOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Big Lots (BIG), up 11.1%... Smith & Wesson (SWHC), up 4.8%... Splunk (SPLK), up 3%... Freeport-McMoRan (FCX), up 14.3% after Carl Icahn reported a 8.46% stake in the company... United Continental (UAL), up 5.8% after being added to S&P 500... Activision Blizzard (ATVI), up 5.8% after being added to S&P 500... DOWN AFTER EARNINGS: Violin Memory (VMEM), down 23.9%... bebe stores (BEBE), down 19.8%... Autodesk (ADSK), down 4.2%... Aeropostale (ARO), down 4%. ALSO LOWER: Peabody Energy (BTU), down 6.6% after Moody's downgraded the company to Caa1.
08:41 EDTSWHCSmith & Wesson reported 'very strong' Q1 results, says RBC Capital
Subscribe for More Information
07:39 EDTORCLOracle volatility elevated into Q1 and outlook
Subscribe for More Information
August 27, 2015
18:52 EDTSWHCOn The Fly: After Hours Movers
Subscribe for More Information
16:19 EDTSWHCSmith & Wesson up 5% after reporting Q1 results, raising FY15 guidance
16:19 EDTSWHCSmith & Wesson raises FY16 EPS view to $1.14-$1.19 from $1.02-$1.07
Subscribe for More Information
16:16 EDTSWHCSmith & Wesson sees Q2 EPS 19c-21c, consensus 15c
Sees Q2 revenue $135M-$140M, consensus $129.58M.
16:13 EDTSWHCSmith & Wesson reports Q1 adjusted EPS 32c, consensus 22c
Subscribe for More Information
10:06 EDTORCLCiti sees Workday guidance confusion as opportunity to buy
Subscribe for More Information
August 26, 2015
10:01 EDTHEBHemispherx says court upholds defense in case brought by Cato Capital
Hemispherx Biopharma announced that on Friday the Third Circuit Court of Appeals upheld the company's defense of a case brought by Cato Capital, one of its former investment banks, thus affirming the trial court judgment Hemispherx obtained in September 2014, when the company fully prevailed in a federal lawsuit brought against the company following trial. The appellate panel affirmed the United States District Court for the District of Delaware, which had dismissed all claims against Hemispherx and subsequently ordered Cato to pay Hemispherx attorney's fees and costs in the amount of $770,852.76.The company's President, Thomas K. Equels, stated: "We are gratified that the distinguished panel vindicated our interpretation of the contract. Our lead counsel, James J. Black, III did an outstanding job interpreting this Delaware law based agreement, and properly navigating this dispute through the courts. Now, in furtherance of our corporate policy to seek redress against plaintiffs who bring meritless claims against the company, we will pursue Cato Capital to the fullest extent of the law to collect on the award of attorney's fees and costs."
07:57 EDTSWHCSmith & Wesson volatility elevated into Q1 and outlook
Smith & Wesson September call option implied volatility is at 57, October is at 46, January is at 49; compared to its 52-week range of 26 to 61, suggesting large near term price movement into the expected release of Q1 results on August 27.
06:44 EDTORCLWorkday valuation contingent on competitors in cloud market, WSJ reports
Subscribe for More Information
August 25, 2015
19:16 EDTORCLTV service Hulu to feature programmatic ads powered by Facebook, Oracle
Subscribe for More Information
07:24 EDTORCLRentrak weakness a buying opportunity, says Brean Capital
Subscribe for More Information
August 24, 2015
08:37 EDTHEBHemispherx enters into supply agreement with Gulf Coast Regional Blood Center
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use